Identification and cDNA cloning of two novel low molecular weight host-protective antigens from Taenia ovis oncospheres

https://doi.org/10.1016/0020-7519(95)00097-6Get rights and content

Abstract

Oncosphere antigens of Taenia ovis were solubilised in sodium dodecyl sulphate and separated by electrophoresis in polyacrylamide gels (SDS-PAGE). Antigen-containing gel fractions cut from the region covering 18–12 kDa were shown to be highly immunogenic in sheep challenge experiments. Specific antisera against 2 candidate antigens at 18 and 16 kDa were used to screen a cDNA library prepared from T. ovis oncosphere mRNA. Recombinant proteins selected with antibody to the 16 and 18 kDa native antigens were expressed as GST fusion proteins. Vaccination trials using either of the 2 fusion proteins To16.17-GST and To18-GST, revealed that each was capable of inducing high levels of immunity in sheep against challenge infection with T. ovis eggs. Antibodies induced by vaccination with the recombinant antigens reacted specifically with their respective 18 or 16 kDa native oncosphere antigens. There was no apparent homology between the T. ovis cDNA coding for To18 and To16.17, or with another host-protective antigen, To45W, described previously. These additional host-protective antigens should prove a valuable adjunct to To45W and permit the development of effective vaccination strategies.

References (14)

There are more references available in the full text version of this article.

Cited by (57)

  • Combined use of two separate but protective vaccine antigens provides protection against Taenia ovis infection in lambs in the presence of protective maternal antibody

    2021, Vaccine
    Citation Excerpt :

    Further evidence for the important role played by complement-fixing antibodies in protection against T. ovis is provided by these antibodies being lethal for T. ovis oncospheres in in vitro culture [8]. Protection of sheep against infection with eggs of T. ovis can be achieved by vaccination with recombinant antigens cloned from oncosphere mRNA [9,10]. High levels of protection by vaccination have been demonstrated against both artificial and naturally-acquired infection [11].

  • Engineering DNA vaccines against infectious diseases

    2018, Acta Biomaterialia
    Citation Excerpt :

    Cons: adjuvants that are commonly used including alum and calcium salts can cause severe inflammation and are not compatible with, or advantageous for, certain antigens [39]. With continual improvements in DNA sequencing technology, we can better understand key conserved sequences that can be transcribed and translated into antigens and discover or engineer sequences that may be used for protection (i.e., TSOL18 [40–42]). Nucleic acid code can be mass produced by DNA recombinant technology, and these codes can be directly delivered and subsequently processed and displayed by APCs for eventual seroconversion by the patient’s own transcription and translation machinery.

  • Immune responses to a recombinant attenuated Salmonella typhimurium strain expressing a Taenia solium oncosphere antigen TSOL18

    2013, Comparative Immunology, Microbiology and Infectious Diseases
    Citation Excerpt :

    Previous animal vaccination experiments using defined proteins, synthetic peptides, recombinant phages, and plasmid DNA have resulted in different levels of protection against experimental T. solium infection [6–11]. A gene encoding T. solium oncosphere antigen TSOL18, a homologue to Taenia ovis To18 [12] and T. saginata TSA18 [13] that induced protective responses in immunized sheep and cattle, respectively, was screened out from a cDNA expression library of T. solium oncospheres [14]. The TSOL18 antigen had been confirmed the existence of a secretory signal at the N terminal and at least one structural domain of Fibronectin III (Fn III) at the C terminal, which is likely to be involved in interactions between oncospheres and intermediate hosts and seems important in inducing host immune protection [15].

View all citing articles on Scopus

Present addresses: AgResearch, NZ Pastoral Agriculture Research Institute Ltd, Wallaceville Animal Research Centre, P.O. Box 40063, Upper Hutt, New Zealand.

**

Present addresses: CSIRO Division of Animal Health, Private Bag No. 1, Parkville, Victoria 3052, Australia

View full text